Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Bioequivalence Study of Sunitinib Malate Capsules in Healthy Volunteers Under Fed Condition.

NCT05800106 is registered in ClinicalTrials.gov with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. as lead sponsor.

NCT NCT05800106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05800106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Bioequivalence Study of Sunitinib Malate Capsules in Healthy Volunteers Under Fed Condition.
Lead sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase
Phase 1
Overall status
Completed
Start date
December 4, 2018
Completion date
January 12, 2019
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal stromal tumors, pancreatic neuroendocrine tumor, renal cell carcinoma